Australian Clinical Labs (ASX:ACL) Operating Cash Flow per Share : A$0.76 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Operating Cash Flow per Share?

Australian Clinical Labs's operating cash flow per share for the six months ended in Dec. 2023 was A$0.37. Australian Clinical Labs's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.76.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Australian Clinical Labs was -6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Australian Clinical Labs's Operating Cash Flow per Share or its related term are showing as below:

ASX:ACL's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Australian Clinical Labs Operating Cash Flow per Share Historical Data

The historical data trend for Australian Clinical Labs's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Operating Cash Flow per Share Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

1.01

1.41

0.71

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial			0.91	0.50	0.32	0.40	0.37

Competitive Comparison of Australian Clinical Labs's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Australian Clinical Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Price-to-Operating-Cash-Flow falls into.

Australian Clinical Labs Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Australian Clinical Labs's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	143.681	/	201.126
	=	0.71

Australian Clinical Labs's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	73.532	/	201.301
	=	0.37

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.76

Australian Clinical Labs Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines